BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $80 at BMO Capital, After FDA CRL
Tweet Send to a Friend
BMO Capital analyst George Farmer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
